Search results
Results from the WOW.Com Content Network
The PFA-100 (Platelet Function Assay [1] or Platelet Function Analyser [2]) is a platelet function analyser that aspirates blood in vitro from a blood specimen into disposable test cartridges through a microscopic aperture cut into a biologically active membrane at the end of a capillary.
The IVY method is the traditional format for this test. While both the IVY and Duke's method require the use of a sphygmomanometer, or blood pressure cuff, the IVY method is more invasive than the Duke method, utilizing an incision on the ventral side of the forearm, whereas the Duke method involves puncture with a lancet or special needle. In ...
Multiplate multiple electrode aggregometry (MEA) is a test of platelet function in whole blood. [1] [2] The test can be used to diagnose platelet disorders, [3] [4] [5] monitor antiplatelet therapy, [6] and is also investigated as a potential predictor of transfusion requirements and bleeding risk in cardiac surgery. [7]
Blood is drawn from the right arm, platelets are extracted using the machine, and the remaining blood components are returned through the left arm. Side effects of the donation of platelets generally fall into three categories: blood pressure changes, problems with vein access, and effects of the anticoagulant on the donor's calcium level.
The PFA-100 (Platelet Function Assay — 100) is a system for analysing platelet function in which citrated whole blood is aspirated through a disposable cartridge containing an aperture within a membrane coated with either collagen and epinephrine or collagen and ADP. These agonists induce platelet adhesion, activation and aggregation, leading ...
Platelet rosetting, or satelliting, around white blood cells can lead to undercounting by automated analyzers. [5] Clotted samples. Coagulation within the sample leads to undercounting, because the analyzer samples the liquid part of the blood, while some of the platelets remain in the tube, trapped in the clot.
Many of the side effects of abciximab are due to its anti-platelet effects which increase the risk of bleeding. The most common type of bleeding due to abciximab is gastrointestinal hemorrhage . Thrombocytopenia is a rare but known serious risk characterized by a severe drop in platelets circulating in the blood.
Unmatched platelets, however, are often used due to the unavailability of matched platelets. [3] They are given by injection into a vein. [4] Side effects can include allergic reactions such as anaphylaxis, infection, and lung injury. [2] Bacterial infections are relatively more common with platelets as they are stored at warmer temperatures. [2]